Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
Date:1/21/2011

therapeutic and diagnostic physics services and educational services to the medical physics community.

For the latest news releases and other corporate documents on Landauer Inc., visit www.landauerinc.com


'/>"/>
SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
3. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
4. Lilly Confirms Date and Conference Call for Fourth-Quarter and Full-Year 2010 Financial Results Announcement
5. VirtualScopics Schedules Third Quarter 2010 Earnings Announcement
6. Lilly Confirms Date and Conference Call for Third-Quarter 2010 Financial Results Announcement
7. Perrigo Confirms Filing for Omeprazole/Sodium Bicarbonate and Announcement of Patent Infringement Lawsuit by Schering-Plough Healthcare Products
8. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
9. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
10. Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma
11. Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... its new YouTube video, “Fireside Convalescent Care Center.” The video informs community members ... video after continually seeing the need for those seeking care to be well ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... premier event and tradeshow, taking place July 29 to August 1. Retail Management ... , ThoughtSpot is a four-day event for independent community pharmacies, where ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June ... $3.1 million grant to study how sensory stimuli can be used to “decrease children’s ... improving care for children with autism, will compare patient experience in a “typical dental ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... Successfully treating and reversing the effects of multiple sclerosis, ... drug originally developed to treat chronic pain, according to ... at Boulder. Watkins and her colleagues in CU-Boulder,s ... injection of a compound called ATL313 -- an anti-inflammatory ...
... Taking time off from certain osteoporosis drugs may be beneficial ... University Health System. Researchers found that bone density remained stable ... from bisphosphonates, a popular class of osteoporosis drugs that can ... the jaw bone. "These drugs are potentially harmful when ...
... at the Harvard School of Public Health (HSPH) and Knowledge ... or cancer believe the economic downturn is hurting their health ... Many Americans with these illnesses face financial problems paying for ... do not believe the new national health care reform law ...
... 18 (HealthDay News) -- A brain area that plays an ... separately to different colors, a new animal study has found. ... could help improve understanding of perception and attention, said the ... "In vision, objects are defined by both their shape ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Nov. ... as an example, new research finds that doctors, prescribing patterns ... from the U.S. Food and Drug Administration. The ... of risk depending on where they live, the researchers said. ...
... D receptors on cancer cells has prompted encouraging responses ... men with prostate cancer that has become resistant to ... clinical trial will be presented at the 22nd EORTC-NCI-AACR ... Berlin today (Thursday). The trial found that when the ...
Cached Medicine News:Health News:Laboratory studies show promise for new multiple sclerosis treatment 2Health News:Taking a break from osteoporosis drugs can protect bones 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 3Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 4Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 2Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 3Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 2Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 3
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: